Chordia Therapeutics (TSE:190A) Other Operating Expense: 円298.66 Mil (TTM As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:190A Chordia Therapeutics Inc TSE:190A
11 GF Score
Price 円74.00
! 1 Warning Sign
View Full Analysis

What is Chordia Therapeutics Other Operating Expense?

Chordia Therapeutics TSE:190A +2.78% 11 Other Operating Expense is 円298.66 Mil as of Feb. 2026. GuruFocus rates TSE:190A with a GF Score™ of 11/100. The stock has 1 warning sign investors should review.

Chordia Therapeutics's Other Operating Expense for the three months ended in Feb. 2026 was 円183.01 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2026 was 円298.66 Mil.

Chordia Therapeutics's quarterly Other Operating Expense declined from Aug. 2025 (円69.46 Mil) to Nov. 2025 (円-30.62 Mil) but then increased from Nov. 2025 (円-30.62 Mil) to Feb. 2026 (円183.01 Mil).

Chordia Therapeutics's annual Other Operating Expense increased from Aug. 2023 (円291.12 Mil) to Aug. 2024 (円301.60 Mil) and increased from Aug. 2024 (円301.60 Mil) to Aug. 2025 (円364.47 Mil).

Chordia Therapeutics Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Chordia Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chordia Therapeutics Other Operating Expense Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24 Aug25
Other Operating Expense
-6.64 -14.56 291.12 301.60 364.47

Chordia Therapeutics Quarterly Data
Aug21 Aug22 May23 Aug23 May24 Aug24 Feb25 May25 Aug25 Nov25 Feb26 May26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 98.41 69.46 -30.62 183.01 76.81
TSE:190A
11GF Score
Chordia Therapeutics Inc TSE:190A
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chordia Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円298.66 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of 円298.66 Mil mean?
Chordia Therapeutics (TSE:190A) has a Other Operating Expense of 円298.66 Mil as of Feb. 2026. Other operating expenses that a company records on its income statement. View historical data on Chordia Therapeutics and its competitors.
Is Chordia Therapeutics' Other Operating Expense too high?
Chordia Therapeutics' current Other Operating Expense is 円298.66 Mil. Overall, Chordia Therapeutics has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Chordia Therapeutics' Other Operating Expense compare to VRTX and REGN?
Chordia Therapeutics' Other Operating Expense of 円298.66 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Chordia Therapeutics and its competitors. Chordia Therapeutics's current Other Operating Expense is 円298.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chordia Therapeutics stock overvalued right now?
Chordia Therapeutics (TSE:190A) has a current Other Operating Expense of 円298.66 Mil. The current Other Operating Expense is 円298.66 Mil. Chordia Therapeutics' overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Chordia Therapeutics (TSE:190A), the current Other Operating Expense is 円298.66 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chordia Therapeutics Business Description

Address 2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
11GF Score

Get the complete analysis for TSE:190A

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円74.00
Price